Jan 09, 2023 / 03:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's great to see everyone back in person again at the conference. It's my pleasure today to be introducing Bristol-Myers Squibb to again kick off the JPMorgan conference. From the company, we have Chris Boerner, the Chief Commercial Officer. And unfortunately, Giovanni was unable to be with us today as he is recovering from COVID.
Before I turn it over to Chris, I did want to remind people that we've moved away from the breakout session format this year at the conference. So we're going to be doing Q&A from the stage after the presentation. And if anybody has any questions, you can use the app to send those to me, and I'll work them into the conversation. So with that, Chris, Happy New Year, thanks for joining us and look forward to the presentation.
Christopher S. Boerner - Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer
Thank you, Chris.
So good morning,
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers